Rankings
▼
Calendar
NAGE Q1 2016 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena
NAGE
Niagen Bioscience Inc
$392M
Q1 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$7M
Gross Profit
$3M
47.1% margin
Operating Income
$454,066
6.2% margin
Net Income
$255,625
3.5% margin
EPS (Diluted)
$0.01
QoQ Revenue Growth
+68.0%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$324,035
Balance Sheet
Total Assets
$17M
Total Liabilities
$10M
Stockholders' Equity
$6M
Cash & Equivalents
$3M
← FY 2016
All Quarters
Q2 2016 →